CEO and Scientific Director
Giulio Superti-Furga, Ph.D., is Scientific Director and CEO of the Research Center of Molecular Medicine of the Austrian Academy of Sciences and Professor of Medical Systems Biology at the Medical University of Vienna. Since 2017 Giulio Superti-Furga has been a member of the Scientific Council of the ERC (European Research Council).
He performed his undergraduate and graduate studies in molecular biology at the University of Zurich, Switzerland, at Genentech Inc., South San Francisco, USA, and at the Institute for Molecular Pathology in Vienna (I.M.P.), Austria. He was a post-doctoral fellow and Team Leader at the European Molecular Biology Laboratory (EMBL) until 2004. For several years he served as professor of Biotechnology at the University of Bologna. In 2000, he co-founded the biotech company Cellzome Inc., where he was Scientific Director and responsible for the Heidelberg research site. His most significant scientific contributions are the elucidation of basic regulatory mechanisms of tyrosine kinases in human cancers and the discovery of fundamental organization principles of the proteome of higher organisms. Giulio Superti-Furga is a member of the Austrian Academy of Sciences and of the German Academy of Sciences Leopoldina. An Italian national born 1962, Giulio Superti-Furga has an Austrian wife and two children.